Zapping the brain without surgery: a new hope for Parkinson's?

NCT ID NCT07698236

ENROLLING_BY_INVITATION Disease control Sponsor: Ruijin Hospital Source: ClinicalTrials.gov ↗

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study tests a noninvasive technique called temporal interference stimulation (TIS) to see if it can improve motor symptoms in people with Parkinson's disease and related conditions. Participants receive both active and sham stimulation in a random order, with each session lasting 30 minutes over three days. The main goal is to measure changes in movement scores using a standard rating scale. If successful, TIS could offer a safer alternative to implanted deep brain stimulators.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Temporal Interference Stimulation (TIS) device
What this could lead to
If effective, this could offer a noninvasive way to improve motor symptoms in Parkinson's disease, potentially reducing the need for invasive deep brain stimulation surgery.
What could go wrong
This is an early-stage crossover study with only 100 participants. The effects may be modest or not last, and individual responses can vary. Risks include discomfort from stimulation and the possibility that sham stimulation may also show some benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital

    Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.